Statistics
Publications
1
Citations
14
H-Index
1
Active since
2022
Affiliations
Mirati Therapeutics (United States)(Current)
Alexander Zhang is an author at Mirati Therapeutics (United States) specializing in molecular drug resistance, parp inhibitor sensitivity, and molecular tumor profiling.
Publications per year
2022–2022
1
1
PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib
Xia Ding, Zhou Zhu, John D. Lapek et al. · Scientific Reports · 2022 · 14 citations · Full text
1–1 of 1